Improvement in obesity-related comorbidities 5 years after endoscopic sleeve gastroplasty: a prospective cohort study.
Ali Lahooti, Donevan Westerveld, Kate Johnson...
https://pubmed.ncbi.nlm.nih.gov/39694295Actively Recruiting
Age: 18Years - 89Years
All Genders
ID04494048
Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
Led by Weill Medical College of Cornell University · Updated on 2026-04-23
9999
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the safety and effectiveness of various endoscopic bariatric therapies (EBTs) used to help with weight loss in people who are obese or have related health issues. These therapies include treatments like intragastric balloons, endoscopic sleeve gastroplasty, and small bowel procedures. The study aims to compare these therapies to other weight loss options by collecting data over time from patients who have undergone these procedures. The study collects information through medical chart reviews and patient visits, focusing on patients who have had or are planning to have EBT within six months. Data gathered includes patient characteristics, laboratory tests, imaging, and sometimes extra blood samples for research. The study follows patients for at least six standard care visits, up to one year after they agree to participate. Participants' progress is monitored through routine visits and medical records, with key measures including changes in body weight at baseline, one month, six months, and one year after the procedure. Researchers also track the safety of the procedures by recording any adverse events at baseline and within 30 days after treatment. Additional outcomes assessed include the success of the therapy, improvement in related health conditions, and effects on reflux or fatty liver disease during follow-up.
CONDITIONS
Brief Title
Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
Who Can Participate
Age: 18Years - 89Years
All Genders
Eligibility Criteria
You may qualify if you...
- Any patient considering undergoing Endoscopic Bariatric Therapy for weight loss within 6 months, or has undergone clinically indicated EBT for weight loss within the past 6 months
- Age 18 years or older
You will not qualify if you...
- Patients who have not undergone or will not undergo Endoscopic Bariatric Therapy for weight loss
- Under 18 years of age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for consenting and initial data collection
Monitoring
Duration - Up to 1 year after the procedure
Participants who undergo Endoscopic Bariatric Therapies are observed through standard of care visits to collect data on weight loss, safety, and efficacy.
At least 6 standard of care visits up to 1 year post procedure
Trial Site Locations
Total: 1 location
1
Weill Cornell Medicine
New York, New York, United States, 10021
Actively Recruiting
Loading map...
Research Team
R
Reem Z Sharaiha, MD, MSc.
A
Andrea M Herr, NP
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here